The Editorial Board comprises key opinion leaders in ALS and FTD. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration aims to disseminate information on new developments in the pathogenesis and management of ALS and FTD, and enhance awareness of these devastating and often under-recognised disorders. The Editors encourage submission of original research, case reports and short reports on all aspects of ALS, frontotemporal dementia and related conditions, including basic science, genetics, new treatments, clinical trials, epidemiology, clinical neurophysiology, and other clinical and scientific aspects.Features include: In-depth reviews Original research Basic science Epidemiology Clinical trials Care issues Ethics and legal issues Health economics Case reports Point-counterpoint debate Correspondence Book reviews ALS centre reports

編輯委員會由ALS和FTD的主要意見領(lǐng)袖組成。肌萎縮側(cè)索硬化癥和額顳葉變性旨在傳播ALS和FTD發(fā)病機制和治療方面的新進展，并提高人們對這些破壞性的、往往未得到充分認識的疾病的認識。編輯鼓勵提交有關(guān)ALS、額顳葉癡呆及相關(guān)疾病的原始研究、病例報告和簡短報告，包括基礎(chǔ)科學(xué)、遺傳學(xué)、新療法、臨床試驗、流行病學(xué)、臨床神經(jīng)生理學(xué)以及其他臨床和科學(xué)方面的研究。功能包括:深入的評論原始研究基礎(chǔ)科學(xué)流行病學(xué)臨床試驗護理問題道德及法律問題衛(wèi)生經(jīng)濟學(xué)案例報告對點的辯論對應(yīng)書評ALS中心報告